IGC is China’s earliest in-depth forum focusing on technological innovation and translation of advanced therapies. Along with the growth of China’s advanced therapy industry (including cell therapy and gene therapy), the IGC conference has a 10-year history – incubated in Wuhan and thriving in Beijing. It has accumulated over 18,500 professional participants from industry, academia, research, hospitals, and capital sectors, and invited more than 780 well-known domestic and international experts, scholars, and R&D scientists from leading enterprises to give speeches. It has effectively promoted the industrial application of immunology, cell therapy, and gene therapy.